Globus Medical, Inc.
Globus Medical, Inc. (GMED) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
gmed · stock forecast · 36 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 36 Wall Street analysts in the past 3 months
Buy
36 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$117
Consensus
$110
+39.1% upside
Low
$100
Median: $112 · Last Close: $79.30
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$110.29
39.1% upside
High Target
$117
47.6%
Low Target
$100
26.1%
Current Price
$79.30
as of today
Based on analyst price targets, the GMED stock price prediction for the next 12 months ranges from $100 to $117. The consensus GMED price forecast of $110.29 implies 39.1% upside from the current price of $79.30.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $78.60 | ↓ 0.88% |
1-day model range: $78.22–$78.97. Peak: $78.97 (-0.88%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $85 | +7.3% |
| 2028 | $89 | +12.3% |
| 2029 | $92 | +15.8% |
| 2030 | $94 | +18.1% |
| 2031 | — | +19.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · GMED · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-08 | Needham | Maintains | Buy→Buy |
| 2026-05-08 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-08 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-02-26 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-02-25 | Barclays | Maintains | Overweight→Overweight |
| 2026-02-25 | Needham | Maintains | Buy→Buy |
| 2026-01-30 | Needham | Upgrade ↑ | Hold→Buy |
| 2026-01-09 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-01-08 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-12-17 | Canaccord Genuity | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Globus Medical, Inc. (GMED) stock. Of the recent 242 rating actions, 24 were upgrades and 25 were downgrades. 36 analysts currently cover GMED.
Analyst Recommendation Trends
GMED analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3.2B
↓ 11.9% YoY
Revenue Next Year
$3.4B
↑ 6.4% YoY
EPS This Year
$4.74
EPS Next Year
$5.15
↑ 8.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast GMED EPS of $4.74 for the current fiscal year, based on estimates from 7 analysts. The GMED revenue forecast is $3.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The GMED stock forecast is supported by two independent data sources: analyst consensus ratings from 36 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GMED price target is $110.29 (+39.1% upside), with an analyst consensus of Buy.
The GMED short-term stock prediction for tomorrow is $78.60 (-0.88%). The GMED stock price prediction for 2027 estimates an average of $85. The GMED stock prediction for 2030 projects a range of $89–$99.
Globus Medical, Inc. trades on NYSE under the ticker GMED. The GMED stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.
Frequently asked questions
GMED forecast · 8 questionsAccording to 36 Wall Street analysts, the average 12-month GMED price target is $110.29, with a high forecast of $117.00 and a low of $100.00. The median price target is shown in the chart above when available. This implies +39.1% potential upside from the current price of $79.30.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.